What is aTyr Pharma, Inc. (ATYR) stock price today?

aTyr Pharma, Inc. (ATYR) currently trades at $0.81 per share. The stock has a market capitalization of $79.17M and a P/E ratio of —x.

Is ATYR stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, aTyr Pharma, Inc. has a Smart Value Score of 27/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is aTyr Pharma, Inc.'s revenue and earnings?

aTyr Pharma, Inc. has trailing twelve-month (TTM) revenue of $190000.00 with profit margins of 0.00%. Earnings per share (EPS) is $-0.80.

ATYR

aTyr Pharma, Inc.

NASDAQ: ATYR · HEALTHCARE · BIOTECHNOLOGY

$0.81

+5.54% today

Updated 2026-04-30

Market cap

$79.17M

P/E ratio

—

P/S ratio

416.67x

EPS (TTM)

$-0.80

Dividend yield

—

52W range

$1 – $7

Volume

1.1M

Market cap

$79.17M

P/E ratio

—

P/S ratio

416.67x

EPS (TTM)

$-0.80

Dividend yield

—

52W range

$1 – $7

Volume

1.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.3

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$4.36

+439.63%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

2 Strong Buy1 Buy6 Hold0 Sell0 Strong Sell

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-12.23M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$10.39M	$353000.00	$235000.00	$190000.00	$190000.00
Net income	$-45.34M	$-50.39M	$-64.02M	$-74.12M	$-13.96M
EPS	—	—	—	—	$-0.80
Free cash flow	$-43.53M	$-37.44M	$-69.18M	$-62.06M	$-12.23M
Profit margin	-436.53%	-14,274.50%	-27,243.83%	-39,009.47%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
ATYR	$79.17M	27	3.3	2.5	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

aTyr Pharma, Inc. trades at $0.81. Our Smart Value Score of 27/100 indicates the stock is weak. TTM revenue stands at $190000.00.

Frequently asked questions

What is aTyr Pharma, Inc.'s stock price?

aTyr Pharma, Inc. (ATYR) trades at $0.81.

Is aTyr Pharma, Inc. overvalued?

Smart Value Score 27/100 (Grade F, Strong Sell).

What is the price target of aTyr Pharma, Inc. (ATYR)?

The analyst target price is $4.36, representing +439.6% upside from the current price of $0.81.

What is aTyr Pharma, Inc.'s revenue?

TTM revenue is $190000.00.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio416.67x

ROE-108.10%

Beta0.65

50D MA$0.86

200D MA$1.79

Shares out0.10B

Float0.10B

Short ratio—

Avg volume1.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

ATYR vs LLY →ATYR vs JNJ →ATYR vs ABBV →Stock screener →